Skip to main content
MS-DRG 123 · MDC 02 · Medical

MS-DRG 123: Neurological Eye Disorders

Compiled from CMS files by the QuickIntell RCM Editorial Team · Data effective · Method: reference methodology · Report a data correction

Data currency: IPPS Table 5 (MS-DRG weights): v44 FY2027 (final rule + CN3) (effective October 1, 2026); MS-DRG Definitions Manual: v44 (effective October 1, 2026). Next CMS release: FY2028 final rule (August 2027), effective October 1, 2027; an April 1 interim grouper update when CMS issues one for the IPPS Table 5 (MS-DRG weights); the FY2028 grouper, effective October 1, 2027 for the MS-DRG Definitions Manual.

Key facts for DRG 123

FY2027 relative weight
0.8220
Higher than 12% of all MS-DRGs
Change vs FY2026
+2.9%
FY2026 weight 0.7986
Geometric mean LOS
2.0 days
Arithmetic mean 2.6 days
MDC
02
Diseases and Disorders of the Eye
Severity level
single severity level
National unadjusted operating payment
$5,629.06
Weight × $6,848.00 FY2027 standardized amount; capital adds $443.84
Transfer policy
Not a transfer DRG

TL;DR

MS-DRG 123 is a medical group in MDC 02 (Diseases and Disorders of the Eye), with no CC/MCC severity split. CMS assigns it a FY2027 relative weight of 0.8220 with a geometric mean length of stay of 2.0 days and an arithmetic mean of 2.6. Its weight moved up 2.9% from FY2026 (0.7986). That weight is higher than 12% of all MS-DRGs. The v44 Definitions Manual assigns it through 210 principal diagnosis codes.

What changed from FY2026 to FY2027

CMS recalibrates every MS-DRG weight annually from the prior year's MedPAR claims. For DRG 123 the FY2027 relative weight is 0.8220 against 0.7986 in FY2026, a rise of 2.93%, which exceeds the 2% threshold worth re-checking in contract models.

FY2026 versus FY2027 payment factors for MS-DRG 123
MetricFY2026FY2027Change
Relative weight0.79860.8220+0.0234
Geometric mean LOS (days)2.12.0-0.1
Arithmetic mean LOS (days)2.62.6+0.0
Weights shown are the FY2027 final values after the 10% cap on year-over-year reductions where applicable.

CC and MCC family

DRG 123 stands alone: CMS does not split this base group by CC or MCC severity, so complication documentation does not move the assignment, although it still affects quality and risk-adjustment reporting.

National unadjusted payment for DRG 123

Multiplying the FY2027 relative weight (0.8220) by the national rates in IPPS Tables 1A and 1D, as corrected by notice CMS-1849-CN3, gives the base amounts below. This group has no CC/MCC sibling, so the amount does not change with secondary-diagnosis capture.

FY2027 national unadjusted IPPS payment for MS-DRG 123
ComponentNational rateDRG 123
Operating (labor and nonlabor share)$4,519.68 + $2,328.32 = $6,848.00$5,629.06
Capital (federal rate)$539.95$443.84
Operating plus capital$6,072.90
Assumes the full annual update (the hospital submitted quality data and is a meaningful EHR user). A hospital with a reduced update starts from $5,452.98 to $5,585.04 for the operating portion of this DRG.

These are national, unadjusted figures, not what a given hospital is paid. The labor share is multiplied by the hospital's wage index (Table 1A applies when the wage index is above 1.0 and Table 1B otherwise), and teaching (IME), disproportionate share (DSH), outlier, transfer and new-technology add-on rules then change the amount for each stay. Use the figures to compare groups and to size a documentation finding, not to forecast a remittance; the DRG payment calculator applies a hospital's own wage index and teaching and DSH factors to DRG 123.

Risk-adjusting diagnoses in this DRG

Appendix B of the v44 Definitions Manual lists 210 ICD-10-CM codes in the logic for DRG 123; 24 of them also map to a CMS-HCC V28 payment category, across 1 category. The same documentation that supports the inpatient group feeds Medicare Advantage risk adjustment when the patient is an MA enrollee.

CMS-HCC V28 categories among the diagnoses in the logic for DRG 123
V28 HCCCategoryShared codesExamples
HCC 298Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage24H34.8110, H34.8111, H34.8112

Grouper logic (v44 Definitions Manual)

Principal Diagnosis: 210 ICD-10-CM codes in this DRG's assignment logic; the first 12 are shown.

Principal Diagnosis codes in the logic for DRG 123 (sample)
ICD-10-CM codeDescription
A39.82Meningococcal retrobulbar neuritis
G45.3Amaurosis fugax
H02.401Unspecified ptosis of right eyelid
H02.402Unspecified ptosis of left eyelid
H02.403Unspecified ptosis of bilateral eyelids
H02.409Unspecified ptosis of unspecified eyelid
H02.421Myogenic ptosis of right eyelid
H02.422Myogenic ptosis of left eyelid
H02.423Myogenic ptosis of bilateral eyelids
H02.429Myogenic ptosis of unspecified eyelid
H02.431Paralytic ptosis of right eyelid
H02.432Paralytic ptosis of left eyelid

Code editor, HAC and CC/MCC exclusion notes for DRG 123

The Definitions Manual lists the diagnosis and procedure codes that lead to DRG 123; these are the ones that are also on a Medicare Code Editor list and can draw that edit.

Medicare Code Editor v44 lists that include codes in the logic of DRG 123
MCE editListCodesExamples
Edit 9unacceptable principal diagnosis20H40.1210, H40.1211, H40.1212
Edit 20unspecified code where a laterality-specific code exists9H34.00, H34.219, H34.8190

Documentation and denial exposure

As a medical DRG, assignment depends on the principal diagnosis sequenced from the attending's documentation; a secondary condition sequenced first, or a symptom code in place of the confirmed diagnosis, changes the MDC or the DRG. Because this family has no severity split, review risk concentrates on medical-necessity of the admission itself and on the two-midnight benchmark. Typical inpatient denial codes for this group: CARC 16 (claim lacks information needed to group the stay), CARC 50 (the admission or procedure is judged not medically necessary), CARC 97 (a service is bundled into the DRG payment).

For teams evaluating QuickIntell software

Evaluate a documentation and coding workflow for DRG 123

Explore QuickCode for qualified coder review and documentation clarification, or QuickScribe for clinician-reviewed visit documentation. Confirm inpatient scope, the supported grouper version and reviewer responsibilities during evaluation. This public reference is not a production grouper and does not determine a claim's reimbursement.

Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.

Frequently asked questions — DRG 123

What is MS-DRG 123?

MS-DRG 123 is "Neurological Eye Disorders", a medical Medicare Severity Diagnosis-Related Group in MDC 02 (Diseases and Disorders of the Eye). Medicare pays inpatient stays grouped here at the hospital's base rate multiplied by the DRG relative weight.

What is the FY2027 relative weight for DRG 123?

The FY2027 relative weight is 0.8220 (IPPS final rule Table 5, effective October 1, 2026). In FY2026 it was 0.7986, a change of +2.9%.

What is the Medicare base payment for MS-DRG 123?

$5,629.06 for operating costs plus $443.84 for capital, $6,072.90 together, at the FY2027 national rates: weight 0.8220 times the $6,848.00 operating standardized amount and the $539.95 capital rate (IPPS Tables 1A and 1D as corrected by CMS-1849-CN3). The hospital's wage index, IME, DSH, outlier and transfer adjustments change what a given stay is paid.

What is the average length of stay for DRG 123?

CMS reports a geometric mean length of stay of 2.0 days and an arithmetic mean of 2.6 days for FY2027. The geometric mean is used for transfer-payment calculations.

What documentation supports the severity level of DRG 123?

DRG 123 has no CC or MCC sibling, so secondary-diagnosis capture does not change the group or its 0.8220 weight. Review effort belongs instead on the principal diagnosis sequencing (210 qualifying principal diagnosis codes) and the procedure codes that place the stay in this group, and on medical necessity of the inpatient admission itself under the two-midnight benchmark against a 2.0-day geometric mean stay, which is where denials for single-severity groups concentrate.

Which codes group to DRG 123?

The v44 Definitions Manual lists 210 principal diagnosis codes for this group. Examples from the principal diagnosis list, A39.82 (Meningococcal retrobulbar neuritis); G45.3 (Amaurosis fugax); H02.401 (Unspecified ptosis of right eyelid); H02.402 (Unspecified ptosis of left eyelid).

Is DRG 123 a post-acute transfer DRG?

No. DRG 123 is not on the FY2027 post-acute care transfer list, so the transfer per-diem policy does not apply to it.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.

Disclaimer

This page is an operational reference compiled from the CMS IPPS FY2027 final rule (Table 5) and the v44 ICD-10 MS-DRG Definitions Manual. Relative weights are national factors; actual payment depends on each hospital's wage-adjusted base rate, add-ons, outliers and transfer adjustments. Nothing here is legal, clinical or billing advice; verify grouping against your encoder and the published CMS files.

Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.